Ronald Peck
Net worth: 461 375 $ as of 2024-05-30
Career history of Ronald Peck
Former positions of Ronald Peck
| Companies | Position | Start | End |
|---|---|---|---|
| ARVINAS, INC. | Chief Tech/Sci/R&D Officer | 2019-07-28 | 2024-03-17 |
| TESARO INC | Chief Tech/Sci/R&D Officer | 2017-03-31 | 2019-06-30 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Chief Tech/Sci/R&D Officer | 2015-07-31 | 2016-11-30 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2011-11-30 | 2015-04-30 |
| University of Virginia | Corporate Officer/Principal | 1997-06-30 | 2000-01-31 |
Training of Ronald Peck
| Georgetown University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Statistics
International
| United States | 8 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ARVINAS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
- Stock Market
- Insiders
- Ronald Peck
- Experience
